care@investkraft.com
+91-9599071040
+91-9797971876
NSE
BSE
Download DRHP
Latest GMP
- Lead Manager
- Axis Capital Limited
- IPO Open Date
- --
- IPO Close Date
- --
- Allotment date
- --
- Listing date
- --
- Issue Size
- --
- Issue Price Band
- --
- Lot Size
- --
- Minimum Investment
- --
Disclaimer: IPO details, GMP, subscription figures, and other related information are for informational purposes only and may not always be accurate or up to date. Please verify the latest details from official sources before investing.
About Veeda Clinical Research Limited
Founded in April 2004, Veeda Clinical Research Limited is a full-service contract research organization (CRO) providing a comprehensive range of services in drug development.
These include non-clinical, pre-clinical, bioavailability, bioequivalence studies, and clinical trials for various drugs such as novel entities, generics, and biosimilars, as well as medical devices.
Key Services
- Early-phase and late-phase clinical trials
- Healthy volunteer studies (HVS), which include bioavailability studies and bioequivalence studies
- Pre-clinical trials and non-clinical testing
- Biopharma services, including non-clinical analysis and clinical bioanalysis of large molecules
Regulatory Track Record
As of September 30, 2024, the company completed 119 global regulatory inspections in HVS and Pre-Clinical services by authorities including the FDA, UK-MHRA, WHO, ANVISA, DCGI, EMA, and NPRA.
Customer Base
As of September 30, 2024, the company has over 436 active clients worldwide.
It has successfully conducted studies for:
- 417 clients during the six months ending September 30, 2024
- 504 clients in Fiscal 2024
- 498 clients in Fiscal 2023
- 580 clients in Fiscal 2022
Workforce
As of September 2024, the company employs 914 people in various departments.
Competitive Strengths
- Established quality credentials with a strong focus on quality control management
- Successful integration of growth opportunities through acquisitions
- Global and diverse management team with deep scientific expertise
IPO Subscription Details
| Category | Shares Offered | Shares Applied | Subscription Times (x) |
|---|
Updated on N/A
Grey Market Premium (GMP)
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Profit* | Last Updated |
|---|
Disclaimer: Grey Market Premium (GMP) is an unofficial market indicator provided for informational purposes only. It may change at any time and should not be considered investment advice or a guarantee of listing gains. Please evaluate company fundamentals, financials, valuation, and subscription data, and consult a SEBI-registered financial advisor before making any investment decision.
Financials of Veeda Clinical Research Limited
A quick overview of the key financial performance of Veeda Clinical Research Limited.
Total Assets (₹ Cr)
Revenue (₹ Cr)
Profit after Tax (₹ Cr)
*All values are in Rs. Cr
Company Financials
Revenue increased by 69%, Profit after Tax (PAT) decreased by 492%, Total Assets increased by 113% between FY2024 (Sep) and FY2025 (Sep).
| Period Ended | FY2022 | FY2023 | FY2024 | FY2024 (Sep) | FY2025 (Sep) |
|---|---|---|---|---|---|
| Revenue | 288.03 | 409.58 | 388.78 | 180.66 | 305.30 |
| Assets | 677.54 | 734.77 | 2,040.21 | 888.11 | 1,891.86 |
| Total Income | 293.11 | 420.21 | 407.99 | 190.04 | 315.87 |
| Profit After Tax | 50.46 | 42.42 | -0.36 | 6.36 | -24.93 |
| EBITDA | 100.97 | 111.39 | 71.21 | 40.69 | 76.56 |
| Net Worth | 503.21 | 564.90 | 1,190.96 | 733.96 | 1,192.51 |
| Reserves & Surplus | 419.58 | 446.58 | 1,047.37 | 592.54 | 1,048.91 |
| Total Borrowings | 47.20 | 48.57 | 261.69 | 38.63 | 405.49 |
Amount in ₹ Crore
IPO Lot Size
IPO lot size details are currently unavailable.
Key Performance Indicators (KPI)
| KPI | Latest |
|---|---|
| Debt / Equity | 0.45 |
| RoNW (%) | -2.13 |
| PAT Margin (%) | -8.17 |
| EBITDA Margin (%) | 25.08 |
|
Pre IPO
Post IPO
|
|
| EPS (₹) |
-3.96
-
|
| P/E (x) |
-
-
|
| Promoter Holding (%) |
33.83
-
|
Disclaimer:
KPI values are based on information disclosed in the IPO prospectus and are provided for informational purposes only.
IPO Lead Manager(s)
Lead Manager Details
- Axis Capital Limited
- Contact Person: Pratik Pednekar
- SEBI Registration Number: INM000012029
- Investor Grievance Email: complaints@axiscap.in
- Website: https://www.axiscapital.co.in
- Email: veeda.ipo@axiscap.in
- Phone: +91 22 4325 2183
- Address: Axis House, 1st Floor, Pandurang Budhkar Marg, Worli, Mumbai 400 025, Maharashtra, India
Lead Manager Details
- CLSA India Private Limited
- Contact Person: Prachi Chandgothia / Purab Sharma
- SEBI Registration Number: INM000010619
- Investor Grievance Email: investor.helpdesk@clsa.com
- Website: https://www.india.clsa.com
- Email: veeda.IPO@clsa.com
- Phone: +91 22 6650 5050
- Address: 8/F Dalamal House, Nariman Point, Mumbai 400021, Maharashtra, India
Lead Manager Details
- IIFL Capital Services Limited
- Contact Person: Yogesh Malpani / Pawan Kumar Jain
- SEBI Registration Number: INM000010940
- Investor Grievance Email: ig.ib@iiflcap.com
- Website: https://www.iiflcapital.com
- Email: veeda.ipo@iiflcap.com
- Phone: +91 22 4646 4728
- Address: 24th Floor, One Lodha Place, Senapati Bapat Marg, Lower Parel (West), Mumbai 400 013, Maharashtra, India
Lead Manager Details
- SBI Capital Markets Limited
- Contact Person: Raghavendra Bhat / Aditya Deshpande
- SEBI Registration Number: INM000003531
- Investor Grievance Email: investor.relations@sbicaps.com
- Website: https://www.sbicaps.com
- Email: veeda.ipo@sbicaps.com
- Phone: +91 22 4006 9807
- Address: 1501, 15th Floor, A & B Wing, Parinee Crescenzo Building, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051, Maharashtra, India
IPO Registrar
- Registrar Name
- MUFG Intime India Private Limited (Formerly Link Intime India Private Limited)
- Phone
- +91 81081 14949
- Contact Person
- Shanti Gopalkrishnan
- SEBI Registration Number
- INR000004058
- Address
- C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai 400 083, Maharashtra, India
- Website
- https://in.mpms.mufg.com/
Company Contact Details
- Company Name
- Veeda Clinical Research Limited
- Phone
- +91 79 6777 3000
- Contact Person
- Nirmal Atmaram Bhatia
- Corporate Identity Number
- U73100GJ2004PLC044023
- Address
- Shivalik Plaza – A, 2nd Floor, Opposite Ahmedabad Management Association, Ambawadi, Ahmedabad 380015, Gujarat, India
Veeda Clinical Research Limited FAQs
The Veeda Clinical Research Limited IPO is a MAIN IPO with a total issue size of
₹ crores.
The IPO price band is fixed at
₹-- to ₹-- per share,
and the minimum lot size is
--.
The Veeda Clinical Research Limited IPO will open on
--,
and will close on
--.
MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) has been appointed as the registrar for the issue.
The equity shares are proposed to be listed on NSE,BSE.
The Veeda Clinical Research Limited IPO opens on -- and closes on --.
The Veeda Clinical Research Limited IPO lot size is --, and the minimum amount required for application is --.
You can apply for the Veeda Clinical Research Limited IPO through your bank account using the ASBA facility or via your online trading and Demat account.
To apply online, log in to your broker’s platform, select Veeda Clinical Research Limited IPO, enter the number of lots, choose your price within the price band, and submit the application.
After submitting, approve the UPI mandate to block the required amount in your bank account.
Once the IPO allotment is finalised, shares will be credited to your Demat account if allotted. If not allotted, the blocked amount will be released automatically.
The Veeda Clinical Research Limited IPO listing date is --.
Investkraft Assistant
Beta Version
Powered by AI
👋 Hi! Before we start, may I know your name?
